{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:54:25Z","timestamp":1781333665501,"version":"3.54.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/wco.0b013e3283533a3f","type":"journal-article","created":{"date-parts":[[2012,4,6]],"date-time":"2012-04-06T20:38:23Z","timestamp":1333744703000},"page":"215-220","source":"Crossref","is-referenced-by-count":24,"title":["Neuromyelitis optica"],"prefix":"10.1097","volume":"25","author":[{"given":"Michael H.","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210206","first-page":"1033","article-title":"Myelite subaigue compliquee de nevrite optique.","volume":"8","author":"Devic","year":"1894","journal-title":"Bull Med (Paris)"},{"key":"R2-2-20210206","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devics syndrome).","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"R3-2-20210206","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R4-2-20210206","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"R5-2-20210206","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"R6-2-20210206","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1352458510376640","article-title":"Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.","volume":"16","author":"Kim","year":"2010","journal-title":"Mult Scler"},{"key":"R7-2-20210206","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"R8-2-20210206","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/1352458510382324","article-title":"Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.","volume":"16","author":"Parratt","year":"2010","journal-title":"Mult Scler"},{"key":"R9-2-20210206","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devics neuromyelitis optica.","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"R10-2-20210206","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.21524","article-title":"Immunoglobulins and complement in postmortem multiple sclerosis tissue.","volume":"65","author":"Barnett","year":"2009","journal-title":"Ann Neurol"},{"key":"R11-2-20210206","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"R12-2-20210206","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"R13-2-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jns.2009.06.014","article-title":"Intractable hiccup caused by medulla oblongata lesions: a study of an autopsy patient with possible neuromyelitis optica.","volume":"285","author":"Kobayashi","year":"2009","journal-title":"J Neurol Sci"},{"key":"R14-2-20210206","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1352458511421185","article-title":"Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy.","volume":"18","author":"Barnett","year":"2012","journal-title":"Mult Scler"},{"key":"R15-2-20210206","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.0b013e3181e2414b","article-title":"Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.","volume":"75","author":"Takano","year":"2010","journal-title":"Neurology"},{"key":"R16-2-20210206","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2990.2010.01105.x","article-title":"Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology.","volume":"36","author":"Lee","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R17-2-20210206","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.","volume":"72","author":"Magana","year":"2009","journal-title":"Neurology"},{"key":"R18-2-20210206","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1073\/pnas.1109980108","article-title":"Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.","volume":"109","author":"Hinson","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-2-20210206","doi-asserted-by":"crossref","first-page":"13609","DOI":"10.1073\/pnas.2235843100","article-title":"Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms.","volume":"100","author":"Furman","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-2-20210206","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1074\/jbc.M110.123000","article-title":"Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding.","volume":"286","author":"Pisani","year":"2011","journal-title":"J Biol Chem"},{"key":"R21-2-20210206","doi-asserted-by":"crossref","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","article-title":"Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4M1M23 isoforms and orthogonal arrays.","volume":"286","author":"Crane","year":"2011","journal-title":"J Biol Chem"},{"key":"R22-2-20210206","doi-asserted-by":"crossref","first-page":"45156","DOI":"10.1074\/jbc.M111.297275","article-title":"Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica.","volume":"286","author":"Ratelade","year":"2011","journal-title":"J Biol Chem"},{"key":"R23-2-20210206","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","article-title":"Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.","volume":"205","author":"Hinson","year":"2008","journal-title":"J Exp Med"},{"key":"R24-2-20210206","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/brain\/awq177","article-title":"Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.","volume":"133","author":"Marignier","year":"2010","journal-title":"Brain"},{"key":"R25-2-20210206","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"R26-2-20210206","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"R27-2-20210206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/72256","article-title":"Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.","volume":"6","author":"Manley","year":"2000","journal-title":"Nat Med"},{"key":"R28-2-20210206","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ana.22551","article-title":"Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Neurol"},{"key":"R29-2-20210206","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci"},{"key":"R30-2-20210206","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic antiaquaporin-4 antibodies in early neuromyelitis optica.","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"R31-2-20210206","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","article-title":"Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.","volume":"68","author":"Kim","year":"2011","journal-title":"Arch Neurol"},{"key":"R32-2-20210206","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes antiaquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-2-20210206","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","article-title":"Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis.","volume":"256","author":"Uzawa","year":"2009","journal-title":"J Neurol"},{"key":"R34-2-20210206","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI25141","article-title":"IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.","volume":"115","author":"Kaplin","year":"2005","journal-title":"J Clin Invest"},{"key":"R35-2-20210206","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/intimm\/10.5.703","article-title":"IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.","volume":"10","author":"Okuda","year":"1998","journal-title":"Int Immunol"},{"key":"R36-2-20210206","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/chan.3735","article-title":"Distribution of the AQP4 water channel in normal human tissues: protein and tissue microarrays reveal expression in several new anatomical locations, including the prostate gland and seminal vesicles.","volume":"1","author":"Mobasheri","year":"2007","journal-title":"Channels (Austin)"},{"key":"R37-2-20210206","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.4049\/jimmunol.0900242","article-title":"Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.","volume":"183","author":"Quintana","year":"2009","journal-title":"J Immunol"},{"key":"R38-2-20210206","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00330-009-1425-3","article-title":"Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study.","volume":"19","author":"Krampla","year":"2009","journal-title":"Eur Radiol"},{"key":"R39-2-20210206","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica.","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"R40-2-20210206","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.21753","article-title":"Cloud-like enhancement is a magnetic resonance imaging abnormality specific to neuromyelitis optica.","volume":"66","author":"Ito","year":"2009","journal-title":"Ann Neurol"},{"key":"R42-2-20210206","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","article-title":"Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.","volume":"67","author":"Palace","year":"2010","journal-title":"Arch Neurol"},{"key":"R43-2-20210206","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","article-title":"IFN-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.","volume":"75","author":"Shimizu","year":"2010","journal-title":"Neurology"},{"key":"R44-2-20210206","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1352458511431973","article-title":"Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.","volume":"18","author":"Min","year":"2012","journal-title":"Mult Scler"},{"key":"R45-2-20210206","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/1352458511404586","article-title":"Impact of rituximab on relapse rate and disability in neuromyelitis optica.","volume":"17","author":"Bedi","year":"2011","journal-title":"Mult Scler"},{"key":"R46-2-20210206","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e31822a2780","article-title":"Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.","volume":"77","author":"Costanzi","year":"2011","journal-title":"Neurology"},{"key":"R47-2-20210206","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jocn.2010.12.011","article-title":"Transient increases in antiaquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels.","volume":"18","author":"Nakashima","year":"2011","journal-title":"J Clin Neurosci"},{"key":"R48-2-20210206","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1111\/j.1468-1331.2007.01807.x","article-title":"Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.","volume":"14","author":"Gartzen","year":"2007","journal-title":"Eur J Neurol"},{"key":"R49-2-20210206","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2169\/internalmedicine.46.0217","article-title":"Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica.","volume":"46","author":"Okada","year":"2007","journal-title":"Intern Med"},{"key":"R50-2-20210206","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1352458506071174","article-title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.","volume":"13","author":"Watanabe","year":"2007","journal-title":"Mult Scler"},{"key":"R51-2-20210206","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archneur.63.7.957","article-title":"Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).","volume":"63","author":"Weinstock-Guttman","year":"2006","journal-title":"Arch Neurol"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0b013e3283533a3f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:12:05Z","timestamp":1620979925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-201206000-00002"}},"subtitle":["not a multiple sclerosis variant"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e3283533a3f","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}